Nicolay, NathalieInnocenti, FrancescoBeauté, JulienUčakar, VeronikaGrgič Vitek, MartaPoukka, EeroHannila-Handelberg, TuulaGauci, CharmaineMelillo, TanyaGeorgakopoulou, TheanoJarkovsky, JiriSlezák, PavelDelgado-Sanz, ConcepcionOlmedo-Lucerón, CarmenSuija, HeleeneLiausediene, RasaO'Lorcain, PiarasMurphy, NiamhPeralta-Santos, AndréCasaca, PedroGregoriou, IoannaBundle, NickSpiteri, GianfrancoRavasi, Giovanni2022-05-092022-05-092021-12Euro Surveill 2021 Dec;26(48):2101030.1560-7917http://hdl.handle.net/20.500.12105/14319Prioritisation of elderly people in COVID-19 vaccination campaigns aimed at reducing severe outcomes in this group. Using EU/EEA surveillance and vaccination uptake, we estimated the risk ratio of case, hospitalisation and death notifications in people 80 years and older compared with 25-59-year-olds. Highest impact was observed for full vaccination uptake 80% or higher with reductions in notification rates of cases up to 65% (IRR: 0.35; 95% CI: 0.13-0.99), hospitalisations up to 78% (IRR: 0.22; 95% CI: 0.13-0.37) and deaths up to 84% (IRR: 0.16; 95% CI: 0.13-0.20).engVoRhttp://creativecommons.org/licenses/by/4.0/COVID-19Health impact assessmentMass vaccinationVaccination uptakeCOVID-19COVID-19 VaccinesAgedHospitalizationHumansSARS-CoV-2VaccinationAtribución 4.0 Internacional348570682648210103010.2807/1560-7917.ES.2021.26.48.21010301560-7917Euro Surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletinopen access